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Abstract (250 words) 
Purpose 
Both intravenous thrombolysis (IVT) and intra-arterial endovascular thrombectomy (ET) improve 
the outcome of patients with acute ischaemic stroke, with ET being an option for those patients with 
large vessel occlusions. Access to ET is currently limited in the England, and we sought to 
understand how organisation of services affects time to treatment for both IVT and ET. 
Method 
A multi-objective optimisation approach was used to explore the relationship between the number 
of IVT and ET centres and times to treatment. The analysis is based on 238,887 emergency stroke 
admissions in England over three years (2013-2015). 
Results 
Providing hyperacute care only in comprehensive stroke centres (CSC, providing both IVT and ET, 
and performing >150 ET per year) in England would lead to 15% of patients being more than 45 
minutes away from care, and would create centres with up to 4,300 stroke admissions/year.  Mixing 
hyperacute stroke units (HASUs, providing IVT only) with CSCs speeds time to IVT and mitigates 
admission numbers to CSCs, but at the expense of time to ET.  Redirecting patients to directly 
attend a CSC by accepting a small delay (15 minute maximum) in IVT reduces time to ET: 30% of 
patients would be redirected from HASUs to a CSC, with an average delay in IVT of 6 minutes, and 
an average improvement in time to ET of 65 minutes.   
Conclusion 
Planning of hyper-acute stroke services is best achieved when considering all forms of acute care 




In England, Wales and Northern Ireland 85,000 people are hospitalised with stroke each year1⁠ and 
stroke is ranked third as a cause of loss of disability-adjusted life years in the UK over the last 25 
years2. Standard care for eligible patients with acute ischaemic stroke within 4.5 hours of onset has 
been intravenous thrombolysis with alteplase (IVT)3⁠. Time from onset to treatment is known to be 
especially critical, with the effectiveness of IVT declining rapidly in the first few hours after 
stroke4. More recently, endovascular thrombectomy (ET) has shown substantially improved clinical 
outcomes in patients with large vessel occlusion (LVO) - present in approximately 40% of 
pateintspatients with acute ischaemic stroke5. ET may be effective up to 6 hours or more after stroke 
onset (depending on patient selection), but also with demonstrates reducing effect sizeiveness with 
increasing time from stroke onset6. The proportion of patients eligible for ET in the UK has been 
estimated at about 10%7⁠. In England the proportion of patients receiving IVT is about 11%1⁠, 
although higher rates have been achieved as a result of reconfiguration of urban hyperacute 
services1,8⁠, with maximum rates of about 20%1⁠. 
Providing ET presents a significant challenge for health services. The procedure is typically carried 
out by a neuro-interventionist and requires support from a whole theatre team (anaesthesia, nurses, 
radiographers) and additional imaging work up, usually with computed tomography angiography 
(CTA), sometimes in association with other advanced imaging techniques (CT perfusion or MRI). 
These additional staffing/infrastructure demands for ET require a more centralised model of service 
provision than currently employed for IVT7,9⁠.  
Two models of hyperacute stroke care have been described and compared10,11⁠. In a ‘mothership’ 
model all services are provided by large centres (comprehensive stroke centres (, CSCs) providing 
both IVT and ET, at the expense of greater travel times for some patients. In a drip and ship model 
local IVT may be delivered at hyper-acute stroke units (HASUs) before transfer of an eligible 
subset of patients with LVO to a CSC (n ET-capable) centre. The choice between these models can 
depend on geography and travel times, availability of experienced staff, urban/rural split, and other 
factors, including the maximum practical size of a CSC under a mothership configuration, and the 
minimum required size of a HASU in a drip and ship model. Exploration of the advantages and 
disadvantages of each model may be explored by computer modelling. 
We have previously used genetic algorithms to identify national configurations of hyper-acute 
stroke services12⁠ that meet national guidelines recommending a minimum number of admissions 
to a HASU of 600 patients per year13⁠, coupled to the recommendation that travel time to 
hyperacute care should be ideally 30 minutes or less, and no more than 60 minutes14⁠. Here we 
apply that validated method to understanding how best ET can be provided at a national level in 
England, and explore how ET and IVT provision interacts. Guidance has been issueds on the 
requirements for training in ET15⁠, both from an individual and training centre perspective., 
Multisociety consensus standards for thrombectomy centres have also been published.16 but no 
Gguidanceelines on the minimum number of cerebral vascular procedures, including ET 
thrombectomy, to maintain individual operator skills (40) has been published nationally, though a 
minimum number of thrombectomy procedures per centre in England has notve yet been 
issueddescribed.15 Rinaldo et al.17⁠ have  demonstrated that patient outcomes in high volume 
centres in the US, with at least 132 ET procedures per year, were better. Rinaldo et al.16⁠ have, 
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however, demonstrated that outcomes in high volume centres in the US, with at least 132 ET 
procedures per year, were better. Additionally, to provide a robust 24/7 ET service realistically 
requires at least 5 operators and, even with some “double scrubbing” on daytime cases, all 5 could 
not hope to meet minimum activity levels to maintain competence if centre cerebral vascular 
interventional volume was <150. We therefore assume a minimum of 150 ET procedures for any 
centre providing ET. There is no guideline on the maximum size of an acute stroke unit, but NHS 
England reconfiguration guidance recommends a maximum of 1,.500 annual admissions for  a 
single team14⁠, and the largest centre currently in the UK has about 2,000 admissions1⁠. 
Method 
We used a genetic algorithm based on NSGA-II187 to derive potential configurations of stroke 
centres across England, balancing competing objectives. Generated solutions are eliminated if 
another solution was equally as good in all optimisation parameters and was better in at least one 
parameter. The selected configurations were based on a range of optimisation parameters which 
seek to minimise travel times and to control admission numbers.  
This location optimisation algorithm, with links to underlying data, has previously been published12. 
The model predicts, for any configuration of stroke centres, the values for each of the competing 
objectives: travel times (estimated fastest road travel time, from home location of patient to 
hospital); number of admissions to each stroke centre.  
We included 238,887 patients coded with ischaemic or haemorrhagic stroke (ICD-10 I61, I63, I64) 
with an emergency admission over a three-year period (2013-2015). Stroke admission numbers 
were counts of admissions for each of 31,771 Lower Super Output Areas (LSOAs) in England. No 
individual patient level data was accessed: counts of admissions per LSOA were extracted from 
Hospital Episode Statistics (HES; http://www.hscic.gov.uk/hes) with access to national HES data 
managed through Lightfoot Solutions (http://www.lightfootsolutions.com/). Estimated fastest road 
travel times were obtained from a geographic information system (Maptitude, with MP-MileCharter 
add-in). These travel times were used for travel time from the patient’s home location to the closest 
stroke unit, and for travel time for onward transfer from a local HASU to the nearest CSC centre if 
required. 
We set a preferred size for any centre providing ET as at least 150 ET procedures per year (as 
outcomes have been shown to be better in centres with at least 132 admissions per year176⁠). In a 
mothership model this would equate to 1,500 admissions/year of confirmed stroke patients if 10%  
were eligible for ET7⁠. In a drip and ship model where patients may first attend a local HASU 
providing IVT only before onward transfer to an ET centre if appropriate, we used a minimum 
centre size of 6003⁠. As the largest stroke centre currently admits about 2,000 patients1⁠, we 
looked for solutions with the least impact on this maximum. 
Outside limited randomised controlled trial data198⁠  there is no published evidence for what the 
organisational delay will be for ET in the UK, but significant transfer-related delays in ET have 
been described. In a large international multi-centre trial (1,000 patients across 55 sites), evaluating 
the use of Medtronic market-released ET devices, patients receiving ET after transfer received ET 
110 minutes later than patients admitted directly, 35 minutes of which was attributable to inter-
hospital travel time, suggesting a net delay of 75 minutes + travel time2019⁠. In our modelling we 
have assumed some improvement over these results and have assumed a 60 minutes net delay in 
addition to the inter-hospital transfer travel time.  
We also sought to model the impact of a preference for ambulance personnel to convey a patient 
with suspected acute stroke directly to an ET-capable CSC, even if a non-ET capable HASU were 
closer.  Again, there is no published or real-world data on the extent of this effect, but expert 
consensus considered that this effect may be at least 15 minutes, and we have termed this parameter 
‘allowable delay’ i.e. an acceptable delay for all patients in arrival at hospital for the sake of a 
proportion who will receive ET sooner through being taken directly to a CSC.  We have not 
modelled any attempt at the pre-hospital selection of patients with potential LVO for selective 
transfer directly to a CSC, but this paradigm is currently under research210⁠. 
Results 
We  examinedWe examined the feasibility of a mothership model by analysing the impact of having 
CSCs at one national centre, up to all current 127 English HASUs1⁠ (figure 1). With all 127 centres 
as CSCs the predicted average patient travel time is 18 minutes, with 90%, 98% and >99% of 
patients within 30, 45 and 60 minutes of their closest CSC. In this configuration, 38% of patients 
attend units with fewer than 600 admissions/year, and 54% of units have fewer than 600 admissions 
per year. If the minimum number of confirmed stroke admissions required to sustain an ET service 
is 1,500 (resulting in ~150 ET procedures per year) then the maximum number of CSCs from the 
solutions identified by the algorithm is 40. The fastest average travel time for solutions with at least 
1,500 admissions per year is 29 minutes, with 62%, 85% and 95% within 30, 45 and 60 minutes of 
their closest centre. Under these parameters, the largest of the 40 CSCs would receive about 3,000 
confirmed stroke admissions per year.  
We examined the distribution of unit sizes in the obtained solutions. For example, 69 solutions were 
identified with 30 CSCs that also had a minimum number of admissions of 1,500. The range in 
admission numbers per year across all solutions was 1,515 to 5,722 (interquartile range [IQR] 
2,071-3,246). 
Such a pure mothership model is highly sensitive to the proportion of patients eligible for ET. If the 
eligibility for ET is different from 10%, or if the minimum number of ET procedures per year is 
adjusted from 150, then the maximum number of sustainable centres will be very different.  If only 
7.5% of stroke patients receive ET and each centre must deliver 200 ET procedures per year, then 
centres must receive at least 2,666 confirmed stroke admissions per year to be sustainable ET 
centres, and the largest number of such centres in England would be 22.  
The most practical starting point for the location of ET centres is the 24 current English 
neurosciences centres, which already have Neurointerventional staff capable to deliver ET and the 
necessary imaging and interventional suite infrastructure to deliver ET.  A mothership model based 
solely on these centres is predicted to have an average travel time of 38 minutes, with 43%, 71% 
and 86% of patients within 30, 45 and 60 minutes of their closest centre. The number of admissions 
to each centre would range from 1,264 to 6,117 (IQR: 2,292-4,169). We compared these 
performance statistics with other configurations of 24 centres (if those centres could be chosen from 
any of the current 127 English HASUs). We made no judgement in the model on the practicality of 
“relocating” any [neuroscience] centre. The fastest average travel times for any 24-unit 
configuration would be of 33 minutes, with 48%, 80% and 93% of patients within 30, 45 and 60 
minutes of their closest centre, with admissions ranging from 1,595 to 7,639 (IQR: 2,092-3,849). 
Admissions could be more even distributed by choosing an alternative 24-centre scenario which 
produces an average travel time of 36 minutes, with 48%, 73% and 88% of patients within 30, 45 
and 60 minutes of their closest centre, and with admissions ranging from 2,236 to 4,382 (IQR: 
2,732-3,978). However, in all these scenarios the upper limit of the pre-set desirable admission 
range (600-2,000) is substantially exceeded in many centres. 
If a pure mothership model is considered unfeasible, then HASUs need to co-exist with the CSCs 
within a drip and ship model of care, whereby patients thought likely to be suitable for ET would 
receive IVT at a HASU (if that centre is their closest centre) and would then be transferred to the 
nearest CSC.  In order to explore the impact of adding HASUs to a configuration of CSCs (moving 
away from a pure mothership model towards a drip and ship model) we took the current 24 
neuroscience centres in England as a baseline CSC configuration, and sequentially added HASUs 
centres from the subset of 103 remaining HASU locations.  We assumed, initially, that patients 
travel first to their closest centre of any type.  All patients eligible for IVT would receive IVT at this 
first centre, but those with LVO likely to benefit from ET will then be transferred to the closest ET 
capable CSC.  In this configuration, we assumed a net delay to ET of 60 minutes for those patients 
taken first to a HASU. 
If additional HASUs are chosen to minimise the average time to arrival at the first centre, increasing 
the number of HASUs reduces average time to IVT, but increases the average time to ET (figure 2).  
With only 24 CSCs in a mothership model, average time to arrival for ET and IVT is 38 minutes, 
with 71% of patients arriving within 45 minutes travel time.  If at the other extreme, the remaining 
103 current English units are present as HASUs in a drip and ship model, the average time to arrival 
for IVT is reduced from 38 to 18 minutes, but the average time to arrival for ET is increased from 
38 to 96 minutes, with only 24% of patients arriving within 45 minutes of stroke onset.  The 
complex relationship between the number of HASUs, travel times and admission numbers for the 
first hospital attended is shown in figure 3.   
If all acute stroke centres have a minimum of 600 admissions/year then the maximum number of 
additional HASUs would be 58 (82 centres in total).  With 82 centres  and all first hospital 
admissions would be between 600 and 1,810 per year (IQR: 781-1,119);.  With 58 additional 
HASUs , average time to arrival for IVT falls from 38 to 22 minutes, with 80%, 94% and 98% of 
patients within 30, 45 and 60 minutes.   However the average time to ET would increase from 38 to 
89 minutes, with only 31% of patients arriving within 45 minutes travel time (travel times include 
an additional 60 minutes net organisational delay).  The algorithm identified 988 solutions where 
annual admissions to all centres are within the range 600 to 2,000; these solutions have between 57 
and 82 centres in total (fromof which the 24 existing neurosciences centres provide ET).  We 
examined the distribution of unit sizes in these obtained solutions.  The range in admission numbers 
per year across all solutions was 601 to 2,000 (IQR: 911-1,394). 
We anticipated that in a mixed system of HASU and CSCs, there may be a preference to convey 
suspected stroke cases directly to the CSC, even if a HASU were closer, a phenomenon we have 
called ‘allowable delay’. A 15 minute allowable delay would mean that the ambulance would 
transfer a patient directly to a more distant CSC so long as there was no more than 15 minutes extra 
travel time. 
We modelled the impact of ‘allowable delay’ in the drip and ship model, with 24 CSCs located at 
the current neuroscience centres and with 103 HASUs at all the remaining centres.  As before, 
assessment and IVT at a nearer HASU incurred a net delay of 60 minutes plus transport time.  In the 
model, patients could be taken straight to a CSC with an allowable delay in IVT of 0-100 minutes, 
applied to all patients.  Generally, allowing a delay in IVT to directly attend a CSC increases 
average time to IVT and decreases average time to ET (figure 4).  However, the effects are not 
equal; allowing up to 15 minutes delay for IVT increases average time to IVT by just 2 minutes 
while reducing average time to ET by 20 minutes. This allowable delay aeffects about 30% of 
patients, who have an average delay in IVT of 6 minutes, and  but an average improvement in time 
to ET of 65 minutes.  
The practice of accepting a delay in IVT for the sake of directly attending a CSC was found to have 
a significant effect on admission numbers to hospitals (figure 5).  As the allowable delay in IVT 
increases, admissions to CSCs increase while admission numbers to HASUs reduce.  With a 15 
minute allowable delay for IVT, the number of centres with fewer than 300 admissions per year 
increases from 7 to 30, while the number of centres with fewer than 600 admissions per year 
increases from 69 to 92 (out of 127 HASUs).  At the same time the number of centres with more 
than 2,500  admissions increases from none to five. With a 30 minute allowable delay for IVT the 
number of centres with fewer than 300 IVT admissions per year increases further sharply to 68, the 
number with fewer than 600 IVT admissions per year increases to 99, and the number with more 
than 2,500 IVT admissions increases to 11.  
The effect of mixing HASUs with 24 CSCs was examined in more detail with an allowable delay in 
IVT of 15 minutes to directly attend a CSC (figure 6).  The maximum total number of centres that 
can maintain at least 600 admissions per year is 54 (reduced from 82 in configurations with no 
allowable delay in IVT).  With this configuration the average time to IVT is 26 minutes with 67%, 
91% and 97% of patients within 30, 45 and 60 minutes of the first admitting centre.  The average 
time to ET is 78 minutes (61% of patients within 45 minutes and 65% within 60 minutes).  
Admission numbers to the first admitting hospital range from 610 to 4,936 (IQR: 789-1,840). 
The on-line appendix contains example maps and more detailed analysis of some specified 
configurations: a 24 CSC mothership model, a 30 CSC mothership model, and a 30 CSC + 50 
HASU drip and ship model with either 0 or 15 minute allowable delay in IVT. 
Discussion 
In an ideal configuration of hyperacute stroke care, all patients would live close to a CSC offering 
high quality acute stroke unit care and both IVT and ET.  Our results suggest that in England, 
providing all acute stroke care in such centres is not likely to be considered feasible.  With our base 
assumptions (10% of patients eligible for ET, and minimum CSC size delivering >150 ET/year) the 
algorithm identified that CSC configurations would have up to 40 centres, however, 15% of stroke 
patients (over 12,000 patients annually) would be further than 45 minutes away from such centres, 
and centres would have to cope with 3,000 or more confirmed stroke admissions per year (the 
largest stroke centre in England currently admits just over 2,000 patients per year1⁠). Additionally 
when considering substantial service reconfiguration there is some uncertainty over the exact 
proportion of stroke patients who will receive ET. 
On this basis, a mixed model of CSCs (offering both IVT and ET) and HASUs (offering only IVT) 
appears necessary. Such a model of care reduces time to admission at the first centre (providing 
IVT) but will delay ET for many eligible patients. The delay comes from additional transport time 
and from organisational delays in arranging/starting onward travel19⁠. The organisational delay 
could be reduced by having ambulances wait at the first-admission hospitals to see if CTA indicates 
that ET is required, or by prioritising ambulance provision for transfer to a CSC. Consideration of 
the substantial impact on ambulance services would need to be given with either of these 
strategies221⁠. 
When planning both IVT and ET services, time to treatment for both procedures and broader issues 
of access to sustainable high quality hyperacute stroke services must be considered. It is possible 
that there could be an ‘over-supply’ of more local IVT services where time to ET is increased 
significantly with minimal improvements in time to IVT. However local HASUs may be required, if 
only to mitigate the number of direct admissions to CSCs. 
Our modelling suggests that allowing a small delay in IVT for patients to be taken straight to a CSC 
may significantly reduce time to ET without significant effect on time to IVT. This is similar to an 
analysis by Froehler et al. who found, in a hypothetical bypass analysis, if patients were brought 
directly to the ET-capable centre, IVT would be slightly delayed (by 12 minutes) but ET would be 
delivered 91 minutes sooner2019⁠. However the population sizes are different – about 30% of all 
patients would have some delay in initial assessment and treatment (with IVT for up to 1 in 5 of 
these patients), whereas only about 1 in 10 of these diverted patients would be expected to benefit 
from improved time to ET. 
Our modelling also anticipates the practicality of implementing a mixed model of HASUs and 
CSCs, in that there may be a preference to convey a patient with suspected stroke to a CSC that is 
more distant, so long as the additional travel time is not excessive.  We have shown that such an 
‘allowable delay’ may significantly reduce time to ET without a substantial adverse effect on 
average time to IVT.  Though models of clinical outcome are in relatively early stages of 
development, a probabilistic model of good outcome is being developed whereby for any individual 
patient it may be determined whether a good outcome is more likely to be achieved by going 
straight to an ET-capable centre rather than first attending a local IVT-only centre10,11⁠. There is, 
however, a potential conflict between making the best decision for any individual patient, and 
making decisions that destabilise the wider services for all patients. Holodinsky et al.11⁠  examined 
the likely outcome of drip and ship vs. mothership models of care, focussing on decisions which 
maximise the likelihood of a good clinical outcome for any individual patient. Such decisions, 
however, may undermine the sustainability of stroke services, either by undermining the capability 
of a local HASU by falling below minimum recommended levels of activity, or by overwhelming 
the capacity of CSCs with very large numbers of suspected stroke patients. The reduction in the size 
of centres may be mitigated, at least in part, by additional expert support to HASUs provided by the 
CSCs, such as the use of telemedicine/teleradiology to support clinical decision making232⁠. By the 
same token, the large numbers of admissions directly to a CSC may be mitigated by the pre-hospital 
selection of patients more likely to have a LVO, and the use of such instruments is currently under 
investigation210⁠. 
It is not only provision of ET that may pull in more patients to a CSC. Advanced imaging 
techniques available there 24/7, but not necessarily elsewhere, may identify patients who might 
benefit from ET whose stroke onset time is either unknown or is longer than would be considered 
for IVT243,254⁠.  
Our model makes assumptions about, and simplifications of, the real world. Indeed, modelling may 
be thought of as the art of abstracting a messy real-world application into a clean problem suitable 
for an algorithmic solution. While not detracting from the key learnings, these simplifications need 
to be born in mind when interpreting our findings. A key assumption is that patients will be taken to 
the closest appropriate stroke centre to their home. We have previously shown that our model 
generally has very good predictability for admission numbers, but the prediction of admission 
numbers is poorer when centres are located close to each other12⁠. When comparing predicted with 
actual admissions there was a median absolute error of 105 admissions per centre per year, or a 
relative absolute error of 17%, but the error was typically about 12% when centres were separated 
by 30 minutes or more travel time, and 20-30% when centres were separated by less than 30 
minutes. This inaccuracy may reflect considerations other than expected travel time, such as on-the-
day traffic conditions, or may reflect a person having a stroke close to, but not actually, at home,  
such as a place of work.  When centres are more closely located such as in city metropolitan areas 
like London, there may therefore be more potential to smooth admissions across centres without a 
significant detrimental effect on travel time. 
We have not taken into account the admission of stroke mimics to centres in these models. Recent 
experience evidence suggests that about 25% of admissions to an acute stroke unit are subsequently 
identified as a stroke mimic265. In large volume centres, stroke mimics have significant impact on 
bed utilisation and infrastructure support.  Improvements in pre-hospital diagnosis of ischaemic 
stroke may in the future lessen the potential impact of stroke mimics on centralised stroke services. 
We have also not considered ischaemic stroke patients who are not recognised to have stroke prior 
to hospital admission.  The majority, but not all, ischaemic stroke patients eligible for IVT and 
nearly all patients suitable for ET are FAST positive276⁠. However these patients may be admitted 
to hospitals without HASUs and require secondary transfer to hospitals with a HASU. 
We have not taken growth in stroke incidence into account in this analysis.  With an ageing 
population, we anticipate a significant increase in admissions to hospital with disabling stroke 
despite better preventative care, particularly in stroke related to atrial fibrillation254. Although such 
forecasting is imprecise, a potential increase in stroke incidence and hospital admissions could be 
driven by a predicted 54% increase in the population of England aged 75 or over the next 15 
years287. These increases may have significant implications for centres close to the lower margin of 
institutional activity in current recommendations.  
Though models always have simplifications, we believe this analytic approach provides some clear 
guidance in regarding provision of ET services.  In England, a mothership model based on 
providing hyperacute stroke care only in CSCs does not look feasible, and so consideration must be 
given to the optimal configuration of a drip and ship model with local HASUs providing IVT and 
transferring eligible patients to a tertiary CSC.  In such a mixed model the HASUs not only help to 
provide more rapid IVT, but they also mitigate admission numbers that directly attend CSCs, thus 
preventing overload of the tertiary CSC and helping maintain flow through patient pathways.  
However, an over-reliance on local HASUs may significantly increase time to ET with little benefit 
to time to IVT, and may also exceed the optimum number of HASUs necessary to control direct 
admissions to CSCs.  When considering individual patients it may appear beneficial to accept a 
short delay in IVT for the sake of direct admission to a more distant CSC for consideration of ET.  
However when considering the overall population disability benefit, this strategy should be applied 
carefully as it has the potential to destabilise both IVT and ET provision by distorting admission 
numbers to both types of centre, risking making many HASUs too small to be sustainable and CSC 
admissions too large to be manageable, to the detriment of all stroke patients not just those eligible 
for IVT &/or ET.  Improvements in pre-hospital diagnosis of stroke due to LVO and stroke mimics 
would enable such a strategy to be implemented with less destabilising effect. 
Conclusion? 
Planning of hyper-acute stroke services is best achieved when considering all forms of acute care 
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Figures 
Figure 1. Feasibility of a mothership model where all patients attend their closest comprehensive stroke centre which provides both IVT and ET. The 
panels show the relationship between the number of centres and best identified results for: (left panel) average and maximum travel time to centre, 
(centre panel) greatest and fewest admissions per year to any single centre, and (right panel) the proportion of patients attending a centre within 45 
minutes and providing at least 150 ET procedures per year.  
 
  
Figure 2. The effect of adding HASUs, with locations chosen to minimise average time to arrival at first hospital, on average time to arrival at hospital 
for IVT (closed circles) and ET (open circles). The base case has 24 CSCs open, located in current neurosciences centres. Onward travel for ET, if 
required, includes the transfer time and an additional 60 min transfer-related delay. 
  
Figure 3.  The effect of adding HASUs on the arrival characteristics of the hospital first attended, assuming all patients first attend their closest centre. 
The panels show the relationship between the number of centres and best identified results for: (left panel) average and maximum travel time to centre, 
(centre panel) greatest and fewest admissions per year to any single centre, and (right panel) the proportion of patients attending a centre within 30 
minutes and admitting at least 600 confirmed stroke patients per year. 
  
Figure 4. For a fixed configuration (with the current neuroscience centres as the 24 CSCs and the remaining 103 existing acute centres as HASUs), the 
effect of allowing a delay in order to travel directly to a CSC (capable of both IVT and ET).  The lines show average time to IVT (solid line) and ET 
(dashed line). 
  
Figure 5. For a fixed configuration (with the current neuroscience centres as the 24 CSCs and the remaining 103 existing acute centres as HASUs), the 
effect on admission numbers of allowing a delay in IVT in order to travel directly to a CSC (capable of both IVT and ET).  The violin plot (left panel) 
shows the range, median (middle bar) and distribution (shaded body) of admissions to the first admitting stroke centre. The line chart (right panel) 
shows the number of centres below or above given threshold s of annual admissions.  
  
Figure 6. The effect of adding HASUs on the arrival characteristics of the hospital first attended, assuming an allowable of up to 15 minutes in order to 
travel directly to a CSC. The panels show the relationship between the number of centres and best identified results for: (left panel) average and 
maximum travel time to centre, (centre panel) greatest and fewest admissions per year to any single centre, and (right panel) the proportion of patients 
attending a centre within 30 minutes and having at least 600 confirmed stroke admissions per year. 
 
